marketcaparena
Search

    KMB

    KIMBERLY CLARK CORP

    Company overview

    Market capitalization
    $32.85B
    Employees
    36,000
    Latest publication
    2026-09-29
    About KIMBERLY CLARK CORP

    Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care products in the United States. It operates in two segments, North America and International Personal Care. The North America segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, facial and bathroom tissue, paper towels, napkins, wipers, tissue, towels, soaps and sanitizers, and other related products under the Huggies, Pull-Ups, Goodnites, Kotex, Poise, Depend, Kleenex, Scott, Cottonelle, Viva, Wypall , and other brand names. Its International Personal Care segment provides baby and child care, adult care and feminine care, including disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Kotex, Goodfeel, Intimus, Depend, and other brand names. The company sells its household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce. It also sells its professional use products through distributors, directly to manufacturing, lodging, office building, food service, and high-volume public facilities, and through e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ4 20052005-12-31 · USDQ1 20022002-03-31 · USDQ4 20002000-12-31 · USDQ3 20002000-09-30 · USDQ2 20002000-06-30 · USDQ1 20002000-03-31 · USDQ4 19991999-12-31 · USD
    Total Revenue4,189,000,000USD4,008,900,000USD3,330,900,000USD3,600,800,000USD3,529,500,000USD3,464,500,000USD3,387,200,000USD3,425,500,000USD
    Cost Of Revenue2,586,000,000USD2,719,300,000USD2,118,500,000USD1,970,000,000USD1,953,900,000USD1,885,100,000USD1,827,800,000USD1,868,400,000USD
    Gross Profit1,603,000,000USD1,289,600,000USD1,212,400,000USD1,630,800,000USD1,575,600,000USD1,579,400,000USD1,559,400,000USD1,557,100,000USD
    Total Operating Expenses970,000,000USD717,400,000USD547,500,000USD971,800,000USD922,400,000USD953,500,000USD967,900,000USD961,600,000USD
    Operating Income633,000,000USD572,200,000USD664,900,000USD659,000,000USD653,200,000USD625,900,000USD591,500,000USD595,500,000USD
    Total Other Income Expense Net-61,000,000USD-87,800,000USD-43,000,000USD-10,900,000USD-31,800,000USD-8,700,000USD80,900,000USD9,100,000USD
    Interest Income4,000,000USD———————
    Interest Expense53,000,000USD190,200,000USD46,700,000USD59,600,000USD58,800,000USD54,000,000USD49,400,000USD—
    Income Before Tax572,000,000USD484,400,000USD621,900,000USD648,100,000USD621,400,000USD617,200,000USD672,400,000USD604,600,000USD
    Income Tax Expense217,000,000USD114,100,000USD185,100,000USD192,400,000USD181,000,000USD182,900,000USD202,200,000USD180,600,000USD
    Equity Method Income Loss55,000,000USD———————
    Discontinued Operations-60,000,000USD0USD0USD0USD0USD0USD0USD—
    Net Income350,000,000USD371,100,000USD439,200,000USD455,700,000USD440,400,000USD434,300,000USD470,200,000USD424,000,000USD
    Minority Interest5,000,000USD24,100,000USD18,600,000USD16,900,000USD18,700,000USD15,400,000USD12,300,000USD—
    Net Income Applicable To Common Shares345,000,000USD383,400,000USD450,600,000USD455,700,000USD440,400,000USD434,300,000USD470,200,000USD—
    Research Development—319,500,000USD79,500,000USD80,400,000USD67,400,000USD68,400,000USD61,200,000USD70,600,000USD
    Selling General Administrative—715,900,000USD566,200,000USD722,900,000USD689,200,000USD717,400,000USD735,300,000USD728,700,000USD
    Unclassified Operating Expenses—-318,000,000USD-98,200,000USD168,500,000USD165,800,000USD167,700,000USD171,400,000USD162,300,000USD
    Net Income From Continuing Ops—0USD0USD0USD0USD0USD0USD—
    Ebit—572,200,000USD664,900,000USD659,000,000USD653,200,000USD625,900,000USD591,500,000USD595,500,000USD
    Ebitda—792,100,000USD835,800,000USD827,500,000USD819,000,000USD793,600,000USD762,900,000USD757,800,000USD
    Depreciation And Amortization—219,900,000USD170,900,000USD168,500,000USD165,800,000USD167,700,000USD171,400,000USD162,300,000USD
    Reconciled Depreciation—219,900,000USD170,900,000USD168,500,000USD165,800,000USD167,700,000USD171,400,000USD162,300,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20002000-12-31 · USDFY 19991999-12-31 · USDFY 19981998-12-31 · USDFY 19961996-12-31 · USDFY 19951995-12-31 · USDFY 19941994-12-31 · USDFY 19931993-12-31 · USDFY 19911991-12-31 · USD
    Total Revenue13,982,000,000USD13,006,800,000USD12,297,800,000USD13,149,100,000USD13,788,600,000USD7,364,200,000USD6,972,900,000USD6,776,900,000USD
    Cost Of Revenue7,636,800,000USD7,095,400,000USD7,088,600,000USD7,680,400,000USD8,246,400,000USD4,595,500,000USD4,285,500,000USD4,066,900,000USD
    Gross Profit6,345,200,000USD5,911,400,000USD5,209,200,000USD5,468,700,000USD5,542,200,000USD2,768,700,000USD2,687,400,000USD2,710,000,000USD
    Research Development277,400,000USD249,800,000USD224,800,000USD—————
    Selling General Administrative2,864,800,000USD2,805,200,000USD2,664,300,000USD2,854,000,000USD3,307,500,000USD1,620,000,000USD——
    Unclassified Operating Expenses673,400,000USD628,000,000USD542,500,000USD561,000,000USD581,700,000USD329,600,000USD1,893,900,000USD1,968,200,000USD
    Total Operating Expenses3,815,600,000USD3,683,000,000USD3,431,600,000USD3,415,000,000USD3,889,200,000USD1,949,600,000USD1,893,900,000USD1,968,200,000USD
    Operating Income2,529,600,000USD2,228,400,000USD1,777,600,000USD2,053,700,000USD1,653,000,000USD819,100,000USD793,500,000USD741,800,000USD
    Interest Expense0USD0USD0USD0USD0USD0USD0USD0USD
    Income Before Tax2,559,100,000USD2,398,300,000USD1,738,900,000USD2,104,600,000USD186,700,000USD811,500,000USD795,300,000USD744,400,000USD
    Income Tax Expense758,500,000USD730,200,000USD561,900,000USD700,800,000USD153,500,000USD276,400,000USD284,400,000USD236,100,000USD
    Net Income1,800,600,000USD1,668,100,000USD1,165,800,000USD1,403,800,000USD33,200,000USD535,100,000USD510,900,000USD508,300,000USD
    Ebit2,529,600,000USD2,228,400,000USD1,777,600,000USD2,053,700,000USD1,653,000,000USD819,100,000USD793,500,000USD741,800,000USD
    Ebitda3,203,000,000USD2,856,400,000USD2,320,100,000USD2,614,700,000USD2,234,700,000USD1,148,700,000USD1,089,400,000USD1,007,300,000USD
    Depreciation And Amortization673,400,000USD628,000,000USD542,500,000USD561,000,000USD581,700,000USD329,600,000USD295,900,000USD265,500,000USD
    Total Other Income Expense Net29,500,000USD169,900,000USD-38,700,000USD50,900,000USD-1,466,300,000USD-7,600,000USD1,800,000USD2,600,000USD
    Minority Interest63,300,000USD———————
    Net Income Applicable To Common Shares1,800,600,000USD———————
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets18,554,000,000USD17,184,000,000USD17,226,000,000USD16,888,000,000USD16,771,000,000USD16,305,000,000USD16,546,000,000USD17,165,000,000USD
    Cash And Equivalents956,000,000USD———————
    Total Current Assets6,354,000,000USD5,291,000,000USD5,310,000,000USD5,474,000,000USD5,557,000,000USD5,281,000,000USD5,580,000,000USD5,847,000,000USD
    Other Current Assets636,000,000USD1,269,000,000USD1,255,000,000USD1,344,000,000USD1,358,000,000USD633,000,000USD728,000,000USD570,000,000USD
    Other Non Current Assets1,036,000,000USD———————
    Total Liabilities16,680,000,000USD———————
    Total Current Liabilities6,988,000,000USD6,903,000,000USD7,125,000,000USD7,077,000,000USD7,171,000,000USD6,921,000,000USD7,004,000,000USD7,066,000,000USD
    Other Current Liabilities2,269,000,000USD———————
    Other Non Current Liabilities622,000,000USD———————
    Total Stockholder Equity1,750,000,000USD1,796,000,000USD1,502,000,000USD1,332,000,000USD1,271,000,000USD1,101,000,000USD840,000,000USD1,285,000,000USD
    Total Equity Including Noncontrolling Interest1,874,000,000USD———————
    Long Term Debt6,474,000,000USD6,475,000,000USD6,474,000,000USD6,470,000,000USD6,470,000,000USD6,481,000,000USD6,875,000,000USD6,882,000,000USD
    Net Receivables1,858,000,000USD2,001,000,000USD1,892,000,000USD1,972,000,000USD2,007,000,000USD2,176,000,000USD2,009,000,000USD2,229,000,000USD
    Inventory1,539,000,000USD1,479,000,000USD1,475,000,000USD1,541,000,000USD1,558,000,000USD1,909,000,000USD1,822,000,000USD1,937,000,000USD
    Property Plant Equipment Net6,948,000,000USD6,833,000,000USD6,775,000,000USD6,530,000,000USD6,317,000,000USD7,507,000,000USD7,513,000,000USD7,703,000,000USD
    Goodwill1,831,000,000USD———————
    Intangible Assets73,000,000USD76,000,000USD77,000,000USD78,000,000USD81,000,000USD85,000,000USD87,000,000USD97,000,000USD
    Accounts Payable3,372,000,000USD3,245,000,000USD3,388,000,000USD2,812,000,000USD3,253,000,000USD3,601,000,000USD3,715,000,000USD3,643,000,000USD
    Short Term Debt43,000,000USD609,000,000USD822,000,000USD771,000,000USD771,000,000USD766,000,000USD683,000,000USD569,000,000USD
    Common Stock473,000,000USD473,000,000USD473,000,000USD473,000,000USD473,000,000USD473,000,000USD473,000,000USD473,000,000USD
    Retained Earnings9,765,000,000USD9,850,000,000USD9,611,000,000USD9,520,000,000USD9,494,000,000USD9,406,000,000USD9,257,000,000USD9,279,000,000USD
    Accumulated Other Comprehensive Income-3,386,000,000USD-3,412,000,000USD-3,444,000,000USD-3,498,000,000USD-3,508,000,000USD-3,635,000,000USD-3,766,000,000USD-3,560,000,000USD
    Total Liab—15,270,000,000USD15,574,000,000USD15,420,000,000USD15,368,000,000USD15,081,000,000USD15,571,000,000USD15,721,000,000USD
    Other Current Liab—3,049,000,000USD2,915,000,000USD3,494,000,000USD3,147,000,000USD2,554,000,000USD2,318,000,000USD2,854,000,000USD
    Capital Stock—473,000,000USD473,000,000USD473,000,000USD473,000,000USD473,000,000USD473,000,000USD473,000,000USD
    Good Will—1,840,000,000USD1,839,000,000USD1,833,000,000USD1,836,000,000USD1,971,000,000USD1,964,000,000USD2,058,000,000USD
    Cash—542,000,000USD688,000,000USD617,000,000USD634,000,000USD563,000,000USD1,021,000,000USD1,111,000,000USD
    Cash And Short Term Investments—542,000,000USD688,000,000USD617,000,000USD634,000,000USD563,000,000USD1,021,000,000USD1,111,000,000USD
    Net Debt—6,542,000,000USD6,608,000,000USD6,624,000,000USD6,607,000,000USD6,684,000,000USD6,895,000,000USD6,340,000,000USD
    Short Long Term Debt—609,000,000USD694,000,000USD834,000,000USD771,000,000USD766,000,000USD568,000,000USD569,000,000USD
    Short Long Term Debt Total—7,084,000,000USD7,296,000,000USD7,241,000,000USD7,241,000,000USD7,247,000,000USD7,916,000,000USD7,451,000,000USD
    Long Term Investments—383,000,000USD330,000,000USD355,000,000USD359,000,000USD354,000,000USD314,000,000USD362,000,000USD
    Property Plant Equipment Gross—16,693,000,000USD16,509,000,000USD16,363,000,000USD16,078,000,000USD19,167,000,000USD18,932,000,000USD19,319,000,000USD
    Common Stock Shares Outstanding—333,200,000shares333,100,000shares333,300,000shares333,300,000shares333,300,000shares334,400,000shares337,200,000shares
    Non Current Assets Total—11,893,000,000USD11,916,000,000USD11,414,000,000USD11,214,000,000USD11,024,000,000USD10,966,000,000USD11,318,000,000USD
    Non Current Liabilities Total—8,196,000,000USD8,449,000,000USD8,343,000,000USD8,197,000,000USD8,160,000,000USD8,567,000,000USD8,655,000,000USD
    Non Current Liabilities Other—623,000,000USD646,000,000USD653,000,000USD680,000,000USD683,000,000USD686,000,000USD751,000,000USD
    Non Currrent Assets Other—2,761,000,000USD2,895,000,000USD2,618,000,000USD2,621,000,000USD1,107,000,000USD1,088,000,000USD1,098,000,000USD
    Net Working Capital—-1,612,000,000USD-1,815,000,000USD-1,603,000,000USD-1,614,000,000USD-1,640,000,000USD-1,424,000,000USD-1,219,000,000USD
    Unclassified Current Liabilities—-609,000,000USD-694,000,000USD-834,000,000USD-771,000,000USD-766,000,000USD-280,000,000USD-569,000,000USD
    Unclassified Non Current Liabilities—1,098,000,000USD1,329,000,000USD1,220,000,000USD1,047,000,000USD996,000,000USD1,006,000,000USD1,022,000,000USD
    Unclassified Equity—-5,588,000,000USD-5,611,000,000USD-5,636,000,000USD-5,661,000,000USD-5,616,000,000USD-5,597,000,000USD-5,380,000,000USD
    Short Term Investments——86,000,000USD———171,000,000USD—
    Unclassified Current Assets——-86,000,000USD———-171,000,000USD—
    Current Deferred Revenue———————-569,000,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets17,226,000,000USD16,546,000,000USD17,344,000,000USD17,970,000,000USD17,837,000,000USD17,523,000,000USD15,283,000,000USD14,518,000,000USD
    Intangible Assets77,000,000USD87,000,000USD197,000,000USD851,000,000USD810,000,000USD832,000,000USD29,000,000USD1,474,000,000USD
    Other Current Assets1,255,000,000USD728,000,000USD520,000,000USD753,000,000USD849,000,000USD733,000,000USD562,000,000USD525,000,000USD
    Total Liab15,574,000,000USD15,571,000,000USD16,276,000,000USD17,270,000,000USD17,100,000,000USD16,654,000,000USD15,089,000,000USD14,564,000,000USD
    Total Stockholder Equity1,502,000,000USD840,000,000USD915,000,000USD700,000,000USD737,000,000USD869,000,000USD-33,000,000USD-287,000,000USD
    Other Current Liab2,915,000,000USD2,318,000,000USD2,286,000,000USD2,030,000,000USD2,476,000,000USD2,621,000,000USD1,969,000,000USD1,878,000,000USD
    Common Stock473,000,000USD473,000,000USD473,000,000USD473,000,000USD473,000,000USD473,000,000USD473,000,000USD473,000,000USD
    Capital Stock473,000,000USD473,000,000USD473,000,000USD473,000,000USD473,000,000USD473,000,000USD473,000,000USD473,000,000USD
    Retained Earnings9,611,000,000USD9,257,000,000USD8,368,000,000USD8,201,000,000USD7,858,000,000USD7,567,000,000USD6,686,000,000USD5,947,000,000USD
    Good Will1,839,000,000USD1,964,000,000USD2,085,000,000USD2,074,000,000USD1,840,000,000USD1,895,000,000USD1,467,000,000USD1,474,000,000USD
    Cash688,000,000USD1,021,000,000USD1,093,000,000USD427,000,000USD270,000,000USD303,000,000USD442,000,000USD539,000,000USD
    Cash And Short Term Investments688,000,000USD1,021,000,000USD1,093,000,000USD427,000,000USD270,000,000USD303,000,000USD442,000,000USD539,000,000USD
    Total Current Assets5,310,000,000USD5,580,000,000USD5,703,000,000USD5,729,000,000USD5,565,000,000USD5,174,000,000USD5,057,000,000USD5,041,000,000USD
    Total Current Liabilities7,125,000,000USD7,004,000,000USD6,930,000,000USD7,334,000,000USD6,749,000,000USD6,443,000,000USD6,919,000,000USD6,536,000,000USD
    Net Debt6,608,000,000USD6,895,000,000USD7,021,000,000USD7,995,000,000USD8,304,000,000USD8,061,000,000USD7,435,000,000USD6,916,000,000USD
    Short Term Debt822,000,000USD683,000,000USD697,000,000USD844,000,000USD433,000,000USD486,000,000USD1,664,000,000USD1,208,000,000USD
    Short Long Term Debt694,000,000USD568,000,000USD567,000,000USD844,000,000USD433,000,000USD486,000,000USD1,534,000,000USD1,208,000,000USD
    Short Long Term Debt Total7,296,000,000USD7,916,000,000USD8,114,000,000USD8,680,000,000USD8,600,000,000USD8,392,000,000USD7,877,000,000USD7,455,000,000USD
    Long Term Debt6,474,000,000USD6,875,000,000USD7,417,000,000USD7,836,000,000USD8,141,000,000USD7,878,000,000USD29,000,000USD64,000,000USD
    Long Term Investments330,000,000USD314,000,000USD306,000,000USD238,000,000USD290,000,000USD300,000,000USD268,000,000USD224,000,000USD
    Short Term Investments86,000,000USD171,000,000USD———300,000,000USD——
    Net Receivables1,892,000,000USD2,009,000,000USD2,135,000,000USD2,280,000,000USD2,207,000,000USD2,235,000,000USD2,263,000,000USD2,164,000,000USD
    Inventory1,475,000,000USD1,822,000,000USD1,955,000,000USD2,269,000,000USD2,239,000,000USD1,903,000,000USD1,790,000,000USD1,813,000,000USD
    Accounts Payable3,388,000,000USD3,715,000,000USD3,653,000,000USD3,813,000,000USD3,840,000,000USD3,336,000,000USD3,055,000,000USD3,190,000,000USD
    Property Plant Equipment Net6,775,000,000USD7,513,000,000USD7,913,000,000USD7,885,000,000USD8,097,000,000USD8,042,000,000USD7,450,000,000USD7,159,000,000USD
    Property Plant Equipment Gross16,509,000,000USD18,932,000,000USD19,151,000,000USD18,549,000,000USD18,528,000,000USD8,042,000,000USD7,450,000,000USD7,159,000,000USD
    Accumulated Other Comprehensive Income-3,444,000,000USD-3,766,000,000USD-3,582,000,000USD-3,669,000,000USD-3,239,000,000USD-3,172,000,000USD-3,294,000,000USD-3,299,000,000USD
    Common Stock Shares Outstanding333,100,000shares337,000,000shares338,800,000shares338,300,000shares338,800,000shares342,500,000shares345,600,000shares349,600,000shares
    Non Current Assets Total11,916,000,000USD10,966,000,000USD11,641,000,000USD12,241,000,000USD12,272,000,000USD12,349,000,000USD10,226,000,000USD9,477,000,000USD
    Non Current Liabilities Total8,449,000,000USD8,567,000,000USD9,346,000,000USD9,936,000,000USD10,351,000,000USD10,211,000,000USD8,170,000,000USD8,028,000,000USD
    Non Current Liabilities Other646,000,000USD686,000,000USD860,000,000USD799,000,000USD681,000,000USD718,000,000USD1,417,000,000USD1,259,000,000USD
    Non Currrent Assets Other2,895,000,000USD1,088,000,000USD1,140,000,000USD546,000,000USD541,000,000USD557,000,000USD1,012,000,000USD620,000,000USD
    Net Working Capital-1,815,000,000USD-1,424,000,000USD-1,227,000,000USD-1,605,000,000USD-1,184,000,000USD-1,269,000,000USD-1,862,000,000USD-1,495,000,000USD
    Unclassified Current Assets-86,000,000USD-171,000,000USD———-300,000,000USD——
    Unclassified Current Liabilities-694,000,000USD-280,000,000USD-287,000,000USD-844,000,000USD-433,000,000USD-486,000,000USD-1,303,000,000USD-3,072,000,000USD
    Unclassified Non Current Liabilities1,329,000,000USD1,006,000,000USD1,069,000,000USD-422,000,000USD-655,000,000USD-267,000,000USD4,559,000,000USD4,530,000,000USD
    Unclassified Equity-5,611,000,000USD-5,597,000,000USD-4,817,000,000USD-4,778,000,000USD355,000,000USD427,000,000USD83,000,000USD75,000,000USD
    Current Deferred Revenue——14,000,000USD647,000,000USD———2,124,000,000USD
    Other Liab———1,723,000,000USD2,184,000,000USD1,882,000,000USD1,654,000,000USD1,717,000,000USD
    Other Assets———1,193,000,000USD1,235,000,000USD1,580,000,000USD645,000,000USD620,000,000USD
    Cash And Equivalents———427,000,000USD270,000,000USD303,000,000USD442,000,000USD539,000,000USD
    Net Tangible Assets———-2,378,000,000USD-2,136,000,000USD-2,101,000,000USD-1,471,000,000USD-1,697,000,000USD
    Unclassified Non Current Assets———-546,000,000USD-541,000,000USD-857,000,000USD-645,000,000USD-2,094,000,000USD
    Treasury Stock————-5,183,000,000USD-4,899,000,000USD-4,454,000,000USD-3,956,000,000USD
    Deferred Long Term Liab——————511,000,000USD458,000,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation360,000,000USD
    Stock Based Compensation64,000,000USD
    Deferred Income Tax-83,000,000USD
    Other Non Cash Items38,000,000USD
    Operating Cash Flow1,653,000,000USD
    Capital Expenditures-776,000,000USD
    Other Investing Activities11,000,000USD
    Investing Cash Flow-765,000,000USD
    Net Debt Issuance677,000,000USD
    Net Common Stock Issuance0USD
    Common Dividends Paid-843,000,000USD
    Other Financing Activities-41,000,000USD
    Unclassified Financing Cash Flow-15,000,000USD
    Financing Cash Flow-222,000,000USD
    Effect Of Forex Changes On Cash-4,000,000USD
    Change In Cash662,000,000USD
    End Cash Flow1,363,000,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20252025-06-30 · USDQ2 20242024-06-30 · USDQ1 20242024-03-31 · USDQ4 20232023-12-31 · USDQ3 20232023-09-30 · USDQ3 20222022-09-30 · USDQ2 20222022-06-30 · USDQ4 20212021-12-31 · USD
    Net Income512,000,000USD544,000,000USD647,000,000USD512,000,000USD591,000,000USD470,000,000USD441,000,000USD357,000,000USD
    Depreciation222,000,000USD188,000,000USD185,000,000USD187,000,000USD189,000,000USD188,000,000USD192,000,000USD194,000,000USD
    Stock Based Compensation41,000,000USD39,000,000USD32,000,000USD38,000,000USD60,000,000USD33,000,000USD52,000,000USD-4,000,000USD
    Other Non Cash Items27,000,000USD86,000,000USD-43,000,000USD32,000,000USD12,000,000USD21,000,000USD17,000,000USD65,000,000USD
    Change In Working Capital5,000,000USD232,000,000USD-372,000,000USD471,000,000USD146,000,000USD182,000,000USD21,000,000USD478,000,000USD
    Total Cash From Operating Activities770,000,000USD1,021,000,000USD438,000,000USD1,215,000,000USD927,000,000USD798,000,000USD740,000,000USD1,062,000,000USD
    Capital Expenditures-197,000,000USD-158,000,000USD-194,000,000USD-217,000,000USD-160,000,000USD-209,000,000USD-217,000,000USD-273,000,000USD
    Free Cash Flow573,000,000USD863,000,000USD244,000,000USD998,000,000USD767,000,000USD589,000,000USD523,000,000USD789,000,000USD
    Investments-193,000,000USD-195,000,000USD-181,000,000USD-152,000,000USD-191,000,000USD-111,000,000USD73,000,000USD-48,000,000USD
    Total Cashflows From Investing Activities-193,000,000USD-195,000,000USD-181,000,000USD-152,000,000USD-266,000,000USD-240,000,000USD-161,000,000USD-320,000,000USD
    Net Borrowings6,000,000USD———-29,000,000USD-78,000,000USD-281,000,000USD-351,000,000USD
    Total Cash From Financing Activities-500,000,000USD-513,000,000USD-485,000,000USD-754,000,000USD-468,000,000USD-489,000,000USD-753,000,000USD-755,000,000USD
    Dividends Paid-419,000,000USD-411,000,000USD-398,000,000USD-399,000,000USD-399,000,000USD-392,000,000USD-391,000,000USD-383,000,000USD
    Sale Purchase Of Stock-59,000,000USD-102,000,000USD-54,000,000USD-130,000,000USD-32,000,000USD-25,000,000USD-24,000,000USD-7,000,000USD
    Change In Cash94,000,000USD310,000,000USD-240,000,000USD279,000,000USD234,000,000USD51,000,000USD-182,000,000USD-16,000,000USD
    Begin Period Cash Flow563,000,000USD853,000,000USD1,093,000,000USD814,000,000USD580,000,000USD311,000,000USD493,000,000USD286,000,000USD
    End Period Cash Flow657,000,000USD1,163,000,000USD853,000,000USD1,093,000,000USD814,000,000USD362,000,000USD311,000,000USD270,000,000USD
    Other Cashflows From Investing Activities36,000,000USD-22,000,000USD-9,000,000USD4,000,000USD283,000,000USD-13,000,000USD-5,000,000USD1,000,000USD
    Other Cashflows From Financing Activities-34,000,000USD-41,000,000USD-40,000,000USD-71,000,000USD-37,000,000USD6,000,000USD-57,000,000USD-14,000,000USD
    Unclassified Operating Cash Flow-37,000,000USD-68,000,000USD-11,000,000USD-25,000,000USD-71,000,000USD-96,000,000USD17,000,000USD-28,000,000USD
    Unclassified Investing Cash Flow161,000,000USD180,000,000USD203,000,000USD213,000,000USD-198,000,000USD93,000,000USD-12,000,000USD—
    Unclassified Financing Cash Flow6,000,000USD41,000,000USD7,000,000USD-154,000,000USD29,000,000USD———
    Change To Account Receivables———127,000,000USD—-151,000,000USD—-37,000,000USD
    Change To Inventory———290,000,000USD—-76,000,000USD—-417,000,000USD
    Change To Liabilities————0USD0USD0USD627,000,000USD
    Cash And Cash Equivalents Changes—————69,000,000USD-174,000,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20232023-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USDFY 20162016-12-31 · USDFY 20152015-12-31 · USDFY 20142014-12-31 · USDFY 20132013-12-31 · USDFY 20122012-12-31 · USD
    Net Income1,764,000,000USD1,410,000,000USD2,278,000,000USD2,166,000,000USD1,013,000,000USD1,526,000,000USD2,142,000,000USD1,750,000,000USD
    Depreciation753,000,000USD882,000,000USD724,000,000USD705,000,000USD746,000,000USD862,000,000USD863,000,000USD857,000,000USD
    Stock Based Compensation169,000,000USD41,000,000USD76,000,000USD77,000,000USD75,000,000USD52,000,000USD92,000,000USD67,000,000USD
    Other Non Cash Items609,000,000USD246,000,000USD68,000,000USD-35,000,000USD1,172,000,000USD518,000,000USD-50,000,000USD271,000,000USD
    Change To Account Receivables127,000,000USD33,000,000USD-44,000,000USD-23,000,000USD60,000,000USD267,000,000USD4,000,000USD-38,000,000USD
    Change To Inventory290,000,000USD-127,000,000USD-33,000,000USD230,000,000USD-28,000,000USD12,000,000USD100,000,000USD9,000,000USD
    Change In Working Capital582,000,000USD389,000,000USD-148,000,000USD334,000,000USD-445,000,000USD-176,000,000USD-158,000,000USD119,000,000USD
    Total Cash From Operating Activities3,542,000,000USD2,970,000,000USD2,929,000,000USD3,232,000,000USD2,306,000,000USD2,845,000,000USD3,040,000,000USD3,288,000,000USD
    Capital Expenditures-766,000,000USD-877,000,000USD-785,000,000USD-771,000,000USD-1,056,000,000USD-1,039,000,000USD-953,000,000USD-1,093,000,000USD
    Free Cash Flow2,776,000,000USD2,093,000,000USD2,144,000,000USD2,461,000,000USD1,250,000,000USD1,806,000,000USD2,087,000,000USD2,195,000,000USD
    Investments-534,000,000USD-353,000,000USD-214,000,000USD-193,000,000USD-146,000,000USD-24,000,000USD-67,000,000USD-189,000,000USD
    Total Cashflows From Investing Activities-418,000,000USD-902,000,000USD-851,000,000USD-732,000,000USD-1,050,000,000USD-770,000,000USD-844,000,000USD-1,184,000,000USD
    Net Borrowings-483,000,000USD66,000,000USD-184,000,000USD-213,000,000USD850,000,000USD1,355,000,000USD59,000,000USD94,000,000USD
    Total Cash From Financing Activities-2,374,000,000USD-2,115,000,000USD-2,421,000,000USD-2,185,000,000USD-1,298,000,000USD-1,893,000,000USD-2,185,000,000USD-1,802,000,000USD
    Dividends Paid-1,588,000,000USD-1,386,000,000USD-1,359,000,000USD-1,311,000,000USD-1,272,000,000USD-1,256,000,000USD-1,223,000,000USD-1,151,000,000USD
    Sale Purchase Of Stock-225,000,000USD-800,000,000USD-911,000,000USD-739,000,000USD-861,000,000USD-1,939,000,000USD-1,216,000,000USD-1,284,000,000USD
    Change In Cash666,000,000USD-77,000,000USD-307,000,000USD304,000,000USD-170,000,000USD-265,000,000USD-52,000,000USD342,000,000USD
    Begin Period Cash Flow427,000,000USD616,000,000USD923,000,000USD619,000,000USD789,000,000USD1,054,000,000USD1,106,000,000USD764,000,000USD
    End Period Cash Flow1,093,000,000USD539,000,000USD616,000,000USD923,000,000USD619,000,000USD789,000,000USD1,054,000,000USD1,106,000,000USD
    Other Cashflows From Investing Activities253,000,000USD-821,000,000USD-820,000,000USD-727,000,000USD-1,068,000,000USD-985,000,000USD114,000,000USD-1,090,000,000USD
    Other Cashflows From Financing Activities-78,000,000USD5,000,000USD33,000,000USD78,000,000USD-15,000,000USD-19,000,000USD195,000,000USD539,000,000USD
    Unclassified Operating Cash Flow-335,000,000USD—-69,000,000USD—-255,000,000USD63,000,000USD151,000,000USD224,000,000USD
    Unclassified Investing Cash Flow629,000,000USD1,149,000,000USD968,000,000USD959,000,000USD1,220,000,000USD1,278,000,000USD62,000,000USD1,188,000,000USD
    Change To Liabilities—392,000,000USD174,000,000USD-61,000,000USD44,000,000USD-30,000,000USD—178,000,000USD
    Exchange Rate Changes—-30,000,000USD36,000,000USD-11,000,000USD-128,000,000USD-447,000,000USD-63,000,000USD40,000,000USD
    Cash And Cash Equivalents Changes—-77,000,000USD-307,000,000USD304,000,000USD-170,000,000USD-265,000,000USD-52,000,000USD342,000,000USD
    Unclassified Financing Cash Flow—————-34,000,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30ProductAdult Care Products493,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductAll Other30,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductBabyandchildcareproducts1,752,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductFamily Care1,015,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductFeminine Care Products423,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductProfessional Products476,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30SegmentInternational Personal Care IPC1,491,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30SegmentNorth America NA2,698,000,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductAdult Care Products483,000,000USD0001628280-26-027800
    Q1 2026Quarterly · 2026-03-31ProductAll Other33,000,000USD0001628280-26-027800
    Q1 2026Quarterly · 2026-03-31ProductBabyandchildcareproducts1,696,000,000USD0001628280-26-027800
    Q1 2026Quarterly · 2026-03-31ProductFamily Care1,040,000,000USD0001628280-26-027800
    Q1 2026Quarterly · 2026-03-31ProductFeminine Care Products451,000,000USD0001628280-26-027800
    Q1 2026Quarterly · 2026-03-31ProductProfessional Products460,000,000USD0001628280-26-027800
    Q1 2026Quarterly · 2026-03-31SegmentInternational Personal Care IPC1,512,000,000USD0001628280-26-027800
    Q1 2026Quarterly · 2026-03-31SegmentNorth America NA2,651,000,000USD0001628280-26-027800
    Q4 2025Quarterly · 2025-12-31SegmentInternational Personal Care IPC1,439,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentNorth America NA2,641,000,000USDLegacy provider
    FY 2025Yearly · 2025-12-31ProductAdult Care Products1,947,000,000USD0001628280-26-007567
    FY 2025Yearly · 2025-12-31ProductAll Other124,000,000USD0001628280-26-007567
    FY 2025Yearly · 2025-12-31ProductBabyandchildcareproducts6,773,000,000USD0001628280-26-007567
    FY 2025Yearly · 2025-12-31ProductFamily Care4,056,000,000USD0001628280-26-007567
    FY 2025Yearly · 2025-12-31ProductFeminine Care Products1,706,000,000USD0001628280-26-007567
    FY 2025Yearly · 2025-12-31ProductProfessional1,841,000,000USD0001628280-26-007567
    FY 2025Yearly · 2025-12-31SegmentInternational Personal Care IPC5,694,000,000USD0001628280-26-007567
    FY 2025Yearly · 2025-12-31SegmentNorth America NA10,753,000,000USD0001628280-26-007567
    Q3 2025Quarterly · 2025-09-30ProductAdult Care Products490,000,000USD0001628280-25-047387
    Q3 2025Quarterly · 2025-09-30ProductAll Other34,000,000USD0001628280-25-047387
    Q3 2025Quarterly · 2025-09-30ProductBabyandchildcareproducts1,685,000,000USD0001628280-25-047387
    Q3 2025Quarterly · 2025-09-30ProductConsumer Tissue Products1,036,000,000USD0001628280-25-047387
    Q3 2025Quarterly · 2025-09-30ProductFeminine Care Products431,000,000USD0001628280-25-047387
    Q3 2025Quarterly · 2025-09-30ProductProfessional Products474,000,000USD0001628280-25-047387
    Q3 2025Quarterly · 2025-09-30SegmentInternational Personal Care IPC1,436,000,000USD0001628280-25-047387
    Q3 2025Quarterly · 2025-09-30SegmentNorth America NA2,714,000,000USD0001628280-25-047387
    Q2 2025Quarterly · 2025-06-30ProductAdult Care Products492,000,000USD0000055785-25-000080
    Q2 2025Quarterly · 2025-06-30ProductAll Other29,000,000USD0000055785-25-000080
    Q2 2025Quarterly · 2025-06-30ProductBabyandchildcareproducts1,768,000,000USD0000055785-25-000080
    Q2 2025Quarterly · 2025-06-30ProductConsumer Tissue Products997,000,000USD0000055785-25-000080
    Q2 2025Quarterly · 2025-06-30ProductFeminine Care Products412,000,000USD0000055785-25-000080
    Q2 2025Quarterly · 2025-06-30ProductProfessional Products465,000,000USD0000055785-25-000080
    Q2 2025Quarterly · 2025-06-30SegmentInternational Personal Care IPC1,433,000,000USD0000055785-25-000080
    Q2 2025Quarterly · 2025-06-30SegmentNorth America NA2,730,000,000USD0000055785-25-000080
    Q1 2025Quarterly · 2025-03-31ProductAdult Care Products476,000,000USD0001628280-26-027800
    Q1 2025Quarterly · 2025-03-31ProductAll Other25,000,000USD0001628280-26-027800
    Q1 2025Quarterly · 2025-03-31ProductBabyandchildcareproducts1,637,000,000USD0001628280-26-027800
    Q1 2025Quarterly · 2025-03-31ProductFamily Care1,027,000,000USD0001628280-26-027800
    Q1 2025Quarterly · 2025-03-31ProductFeminine Care Products443,000,000USD0001628280-26-027800
    Q1 2025Quarterly · 2025-03-31ProductProfessional Products446,000,000USD0001628280-26-027800
    Q1 2025Quarterly · 2025-03-31SegmentInternational Personal Care IPC1,386,000,000USD0001628280-26-027800
    Q1 2025Quarterly · 2025-03-31SegmentNorth America NA2,668,000,000USD0001628280-26-027800
    FY 2024Yearly · 2024-12-31ProductAdult Care Products1,864,000,000USD0001628280-26-007567
    FY 2024Yearly · 2024-12-31ProductAll Other84,000,000USD0001628280-26-007567
    FY 2024Yearly · 2024-12-31ProductBabyandchildcareproducts7,056,000,000USD0001628280-26-007567
    FY 2024Yearly · 2024-12-31ProductFamily Care3,928,000,000USD0001628280-26-007567
    FY 2024Yearly · 2024-12-31ProductFeminine Care Products1,721,000,000USD0001628280-26-007567
    FY 2024Yearly · 2024-12-31ProductProfessional2,152,000,000USD0001628280-26-007567
    FY 2024Yearly · 2024-12-31SegmentInternational Personal Care IPC5,743,000,000USD0001628280-26-007567
    FY 2024Yearly · 2024-12-31SegmentNorth America NA11,017,000,000USD0001628280-26-007567
    Q3 2024Quarterly · 2024-09-30ProductAdult Care Products466,000,000USD0001628280-25-047387
    Q3 2024Quarterly · 2024-09-30ProductAll Other22,000,000USD0001628280-25-047387
    Q3 2024Quarterly · 2024-09-30ProductBabyandchildcareproducts1,721,000,000USD0001628280-25-047387
    Q3 2024Quarterly · 2024-09-30ProductConsumer Tissue Products989,000,000USD0001628280-25-047387
    Q3 2024Quarterly · 2024-09-30ProductFeminine Care Products437,000,000USD0001628280-25-047387
    Q3 2024Quarterly · 2024-09-30ProductProfessional Products509,000,000USD0001628280-25-047387
    Q3 2024Quarterly · 2024-09-30SegmentInternational Personal Care IPC1,409,000,000USD0001628280-25-047387
    Q3 2024Quarterly · 2024-09-30SegmentNorth America NA2,735,000,000USD0001628280-25-047387
    Q2 2024Quarterly · 2024-06-30ProductAdult Care Products455,000,000USD0000055785-25-000080
    Q2 2024Quarterly · 2024-06-30ProductAll Other19,000,000USD0000055785-25-000080
    Q2 2024Quarterly · 2024-06-30ProductBabyandchildcareproducts1,814,000,000USD0000055785-25-000080
    Q2 2024Quarterly · 2024-06-30ProductConsumer Tissue Products939,000,000USD0000055785-25-000080
    Q2 2024Quarterly · 2024-06-30ProductFeminine Care Products413,000,000USD0000055785-25-000080
    Q2 2024Quarterly · 2024-06-30ProductProfessional Products591,000,000USD0000055785-25-000080
    Q2 2024Quarterly · 2024-06-30SegmentInternational Personal Care IPC1,427,000,000USD0000055785-25-000080
    Q2 2024Quarterly · 2024-06-30SegmentNorth America NA2,783,000,000USD0000055785-25-000080
    Q1 2024Quarterly · 2024-03-31ProductAdult Care Products463,000,000USD0000055785-25-000039
    Q1 2024Quarterly · 2024-03-31ProductAll Other24,000,000USD0000055785-25-000039
    Q1 2024Quarterly · 2024-03-31ProductBabyandchildcareproducts1,773,000,000USD0000055785-25-000039
    Q1 2024Quarterly · 2024-03-31ProductConsumer Tissue Products1,599,000,000USD0000055785-25-000039
    Q1 2024Quarterly · 2024-03-31ProductFeminine Care Products467,000,000USD0000055785-25-000039
    Q1 2024Quarterly · 2024-03-31ProductProfessional Products823,000,000USD0000055785-25-000039
    FY 2023Yearly · 2023-12-31ProductAdult Care Products1,809,000,000USD0001628280-26-007567
    FY 2023Yearly · 2023-12-31ProductAll Other87,000,000USD0001628280-26-007567
    FY 2023Yearly · 2023-12-31ProductBabyandchildcareproducts7,054,000,000USD0001628280-26-007567
    FY 2023Yearly · 2023-12-31ProductFamily Care4,024,000,000USD0001628280-26-007567
    FY 2023Yearly · 2023-12-31ProductFeminine Care Products1,787,000,000USD0001628280-26-007567
    FY 2023Yearly · 2023-12-31ProductProfessional2,385,000,000USD0001628280-26-007567
    FY 2023Yearly · 2023-12-31SegmentInternational Personal Care IPC5,940,000,000USD0001628280-26-007567
    FY 2023Yearly · 2023-12-31SegmentNorth America NA10,996,000,000USD0001628280-26-007567
    FY 2022Yearly · 2022-12-31ProductAdult Care Products1,730,000,000USD0000055785-25-000013
    FY 2022Yearly · 2022-12-31ProductAll Other85,000,000USD0000055785-25-000013
    FY 2022Yearly · 2022-12-31ProductAway From Home Professional Products3,256,000,000USD0000055785-25-000013
    FY 2022Yearly · 2022-12-31ProductBabyandchildcareproducts7,166,000,000USD0000055785-25-000013
    FY 2022Yearly · 2022-12-31ProductConsumer Tissue Products6,243,000,000USD0000055785-25-000013
    FY 2022Yearly · 2022-12-31ProductFeminine Care Products1,695,000,000USD0000055785-25-000013
    FY 2022Yearly · 2022-12-31SegmentConsumer Tissue6,243,000,000USD0000055785-24-000018
    FY 2022Yearly · 2022-12-31SegmentCorporate And Other54,000,000USD0000055785-24-000018
    FY 2022Yearly · 2022-12-31SegmentKCProfessional3,256,000,000USD0000055785-24-000018
    FY 2022Yearly · 2022-12-31SegmentPersonal Care10,622,000,000USD0000055785-24-000018
    FY 2021Yearly · 2021-12-31ProductAll Other3,100,000,000USD0000055785-24-000018
    FY 2021Yearly · 2021-12-31ProductAway From Home Professional Products3,100,000,000USD0000055785-24-000018

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.